South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
Human HIV Vaccine Trial Begins With BRILLIANT 011
Original Article by Yoliswa Sobuwa | Sunday Times | 1 February 2026
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.